Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingrui Jiang

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Genes & Cancer|July 23, 2011
Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent MannerJingrui Jiang, James D Griffin
Journal of Affective Disorders|September 1, 2023
Sexual orientations in association between childhood maltreatment and depression among undergraduates in mainland of ChinaJingrui Jiang, Yafei Tan, Chang Peng
Journal of Personalized Medicine|April 13, 2018
Genomic Profiling on an Unselected Solid Tumor Population Reveals a Highly Mutated Wnt/β-Catenin Pathway Associated with Oncogenic EGFR MutationsJingrui Jiang, Alexei Protopopov, Ruobai Sun, et al.
Cancer Research|October 6, 2005
Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progressionJingrui Jiang, Heidi Greulich, Pasi A Jänne, et al.
Molecular & Cellular Proteomics : MCP|December 19, 2009
A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemiaYi Zhang, Manor Askenazi, Jingrui Jiang, et al.
Free Radical Biology & Medicine|December 21, 2020
The role of NO in COVID-19 and potential therapeutic strategiesWanyi Fang, Jingrui Jiang, Lei Su, et al.
Oncotarget|July 2, 2016
IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancerHengmi Cui, Yuan Liu, Jingrui Jiang, et al.
Cancer Research|November 13, 2003
Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activityJingrui Jiang, Christian B Matranga, Dongpo Cai, et al.
The Lancet. Microbe|March 19, 2023
Advances in developing ACE2 derivatives against SARS-CoV-2Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
Genes & Cancer|July 23, 2011
Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity ComparisonEllen Weisberg, Johannes Roesel, Pascal Furet, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Genes & Cancer|July 23, 2011
Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent MannerJingrui Jiang, James D Griffin
Journal of Affective Disorders|September 1, 2023
Sexual orientations in association between childhood maltreatment and depression among undergraduates in mainland of ChinaJingrui Jiang, Yafei Tan, Chang Peng
Journal of Personalized Medicine|April 13, 2018
Genomic Profiling on an Unselected Solid Tumor Population Reveals a Highly Mutated Wnt/β-Catenin Pathway Associated with Oncogenic EGFR MutationsJingrui Jiang, Alexei Protopopov, Ruobai Sun, et al.
Cancer Research|October 6, 2005
Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progressionJingrui Jiang, Heidi Greulich, Pasi A Jänne, et al.
Molecular & Cellular Proteomics : MCP|December 19, 2009
A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemiaYi Zhang, Manor Askenazi, Jingrui Jiang, et al.
Free Radical Biology & Medicine|December 21, 2020
The role of NO in COVID-19 and potential therapeutic strategiesWanyi Fang, Jingrui Jiang, Lei Su, et al.
Oncotarget|July 2, 2016
IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancerHengmi Cui, Yuan Liu, Jingrui Jiang, et al.
Cancer Research|November 13, 2003
Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activityJingrui Jiang, Christian B Matranga, Dongpo Cai, et al.
The Lancet. Microbe|March 19, 2023
Advances in developing ACE2 derivatives against SARS-CoV-2Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
Genes & Cancer|July 23, 2011
Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity ComparisonEllen Weisberg, Johannes Roesel, Pascal Furet, et al.
Pageof 3